Showing posts with label health technology. Show all posts
Showing posts with label health technology. Show all posts

Sunday, 31 May 2015

Co-production in practice

"The low uptake of telecare and telehealth services by older people may be explained by the limited involvement of users in the design."

Co-production in practice: how people with assisted living needs can help design and evolve technologies and services
J Wherton, P Sugarhood, R Procter, S Hinder, T Greenhalgh
Implementation Science, 2015, 10:75

Read more here.

Monday, 13 January 2014

Capturing value from health technologies in lean times

"The adoption of new health technologies brings potential improvements to quality of life as well as new costs for provincial healthcare systems."

Capturing value from health technologies in lean times
Commentary no.396
A Blomqvist, C Busby, D Husereau
C.D. Howe Institute
December 2013

Read more here.

Read a summary from the Commissioning Elf here.

Tuesday, 17 December 2013

Toward new models for innovative governance of biomedicine and health technologies

"To efficiently translate biomedicine and health technologies from the laboratory bench to the bedside, governance frameworks are having to change to take into account the complexity of the field, using new (and often) iterative regulatory processes."

Toward new models for innovative governance of biomedicine and health technologies
OECD Science, Technology and Industry Policy Papers No.11
December 2013

Read more here.

Sunday, 6 November 2011

Use of health technology assessment to inform the value of provider fees

"Health technology assessment (HTA) is becoming an increasingly prominent policy tool in response to concerns about rising healthcare costs driven by the use of technology."

The use of health technology assessment to inform the value of provider fees: current challenges and future opportunities
D Husereau, CG Cameron
Canadian Health Services Research Foundation
October 2011

Read more here.

Saturday, 29 October 2011

Uncertainty, evidence and irrecoverable costs

"This research was commissioned to inform when NICE should approve health technologies only in research (OIR) or with research (AWR)."


Uncertainty, evidence and irrecoverable costs: Informing approval, pricing and research decisions for health technologies
K Claxton, S Palmer, L Longworth, L Bojke, S Griffin, C McKenna, M Soares, E Spackman, J Youn
Centre for Health Economics
October 2011

Read more here.

Saturday, 10 September 2011

Product development partnerships

"PDPs reflect the current phase in the history of health technology development: the Era of Partnerships, in which the public and private sectors have found productive ways to collaborate."

Product development partnership: case studies of a new mechanism for health technology innovation
RT Mahoney
Health Research Policy and Systems, 2011, 9:33

Read more here.